Rare Disease Month: Translating Rare Disease Innovations from Bench to Bedside

Joff Masukawa is the founder of Diligentia Strategy, a life-sciences consultancy specializing in development of commercial strategies and tactical plans for manufacturers of rare orphan and specialty drugs, cell and gene therapies, digital therapeutics and other emerging medical innovations.

Join the VCU Medical Center Health and Wellness Library on Zoom on Feb 19 at noon to learn more about Joff’s work supporting the rare disease community, including the obstacles and opportunities, and how to maximize the probability of translating a medical innovation to market.

This program is free and open to all. Registration is required. Registrants will receive a Zoom link to the program on the day of the event.